What steps can be taken to improve equitable access to diagnostic testing? Medical laboratory scientist Dr. Rodney Rohde shares his expert perspective.

What are the factors that impact imaging disparities, and how can these imaging disparities be overcome for better health outcomes?

What does a holistic examination of diagnostic error disparities look like? Medical researchers from The Society to Improve Diagnosis in Medicine (SIDM) and Johns Hopkins University examined and attacked the question head-on.

What kind of diagnostic testing disparities in race, age, and sex are patients up against for obtaining echocardiograms in the U.S., and how can heart health outcomes be overcome?

Why would a doctor want to track bilirubin levels after starting a patient on new medication? Medical laboratory scientist Dr. Kyle Riding explains reasons to track.

Can elevated bilirubin usually lead to hemolytic anemia complications? Medical laboratory scientist Dr. Kyle Riding explains how elevated bilirubin levels may occur and potential complications.

What are laboratory values that help determine issues with bilirubin and hemolysis? Medical laboratory scientist Dr. Kyle Riding explains.

What factors contribute to diagnostic testing inequities in men? Dr. Kyle Riding discusses social and cultural factors for men and ways to change male thinking about health care.

What is the role of implicit bias in diagnostic inequities? Dr. Kyle Riding discusses implicit bias and how it can be addressed to improve health outcomes.

What exactly is bilirubin? Expert Dr. Kyle Riding explains how bilirubin is involved in body processes and what the different bilirubin lab values mean.

Diverse Health Hub and its Pro Hub members are proud to have participated in the COLA Laboratory Enrichment Forum this year in Florida. Read to learn more about COLA.

How can optimization of medications for diverse groups be aided by HCPs? Dr. Brandy Gunsolus and Dr. Dana Powell Baker explain.

How can misdiagnosis result from unconscious bias? Dr. Brandy Gunsolus and Dr. Dana Powell Baker share their perspectives and personal medical experiences with bias.

How can clinical trial participation and laboratory validations be increased for BIPOC and minority patients? Dr. Marilyn Bibbs Freeman discusses ways and places to build medical trust with underrepresented patients.

How can work toward equitable care delivery be aided by laboratory scientists? Dr. Brandy Gunsolus and Dr. Dana Powell Baker share their perspectives and hopes for the future.

What are some unconscious bias issues and solutions for interpreting lab values? Dr. Brandy Gunsolus and Dr. Dana Powell Baker share their perspectives.

What work is being carried out to help ensure lab test accuracy for diverse populations? Laboratory scientist Dr. Dana Powell Baker discusses standardization efforts.

Do drug metabolism enzymes vary by racial and ethnic groups? Dr. Brandy Gunsolus and Dr. Dana Powell Baker discuss the history of race correction in drug metabolism.

How can clinical practice be an accurate reflection of racial and ethnic differences? Dr. Brandy Gunsolus and Dr. Dana Powell Baker share their perspectives.

How have laboratory medicine practices used race-based corrections? Dr. Brandy Gunsolus discusses race-based corrections, patient impacts, and where things stand today.